Phase I/II dose escalation study of recombinant human interleukin‐11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study*Mitchell S. Cairo, Gregory H. Reaman, Rita Secola et al.|British Journal of Haematology|2004Cited by 32
Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC)Ilse Houtenbos, MS Cairo, Francisco Bracho et al.|Bone Marrow Transplantation|2001Cited by 20
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.Francisco Bracho, Mitchell S. Cairo, Mark Krailo et al.|PubMed|2001Cited by 17
Feasibility Study of IL-11 and Granulocyte Colony-Stimulating Factor After Myelosuppressive Chemotherapy to Mobilize Peripheral Blood Stem Cells From Heavily Pretreated PatientsStanton Goldman, Mitchell S. Cairo, Joel Weinthal et al.|The American journal of pediatric hematology/oncology|2001Cited by 16